ACVR1 | 6TN8 | 06/12/2019 | ACVR1 | Cancer | Oxford | MedChem |
ACVR1 | 6T8N | 24/10/2019 | ACVR1 | Cancer | Oxford | MedChem |
ACVR1 | 6T6D | 18/10/2019 | ACVR1 | Cancer | Oxford | MedChem |
ACVR1 | 6SZM | 02/10/2019 | ACVR1 | Cancer | Oxford | MedChem |
DHTKD1 | 6SY1 | 26/09/2019 | DHTKD1 | Metabolism | Oxford | Counted |
ACVR1 | 6SRH | 05/09/2019 | ACVR1 | Cancer | Oxford | MedChem |
BRD4 | 6SE4 | 29/07/2019 | BRD4 | Cancer and epigenetics | Oxford | MedChem |
RAB39B | 6S5F | 01/07/2019 | RAB39B | Cancer | Oxford | Counted |
RAB38 | 6S5H | 01/07/2019 | RAB38 | Cancer | Oxford | Counted |
ACVR1A | 6GI6 | 07/02/2019 | ACVR1 | | Oxford | Follow-up not counted |
SLC14A1A | 6QD5 | 31/12/2018 | SLC14A1 | | Oxford | Official |
KCTD16A | 6QB7 | 20/12/2018 | KCTD16 | | Oxford | Official |
SPIN1A | 6I8Y | 22/11/2018 | SPIN1 | | Oxford | Follow-up not counted |
SPIN1A | 6I8L | 21/11/2018 | SPIN1 | | Oxford | Follow-up not counted |
SPIN1A | 6I8B | 20/11/2018 | SPIN1 | | Oxford | Follow-up not counted |
STK10A | 6I2Y | 02/11/2018 | STK10 | | Oxford | Follow-up not counted |
STK10A | 6HXF | 17/10/2018 | STK10 | | Oxford | Follow-up not counted |
SLKA | 6HVD | 11/10/2018 | SLK | | Oxford | Follow-up not counted |
DDR1A | 6HP9 | 19/09/2018 | DDR1 | | Oxford | Follow-up not counted |
RIOK2A | 6HK6 | 05/09/2018 | RIOK2 | | Oxford | Official |
DYRK2 | 6HDP | 18/08/2018 | DYRK2 | Cancer | Oxford | MedChem |
DYRK2 | 6HDR | 18/08/2018 | DYRK2 | Cancer | Oxford | MedChem |
HCN4A | 6GYN | 30/06/2018 | HCN4 | | Oxford | Official |
HCN4A | 6GYO | 30/06/2018 | HCN4 | | Oxford | Official |
DDR1A | 6GWR | 25/06/2018 | DDR1 | | Oxford | |
STK10A | 6GTT | 18/06/2018 | STK10 | | Oxford | Follow-up not counted |
NUDT5A | 6GRU | 12/06/2018 | NUDT5 | | Oxford | Follow-up official |
AURKC | 6GR8 | 10/06/2018 | AURKC | Cancer | Oxford | Counted |
AURKC | 6GR9 | 10/06/2018 | AURKC | Cancer | Oxford | Follow-up official |
STK6 | 6GRA | 10/06/2018 | AURKA | Cancer | Oxford | MedChem |
GALTA | 6GQD | 07/06/2018 | GALT | Metabolism | Oxford | Follow-up official |
ACVR1A | 6GIP | 14/05/2018 | ACVR1 | | Oxford | |
ACVR1A | 6GIN | 14/05/2018 | ACVR1 | | Oxford | |
SP100A | 6G5N | 29/03/2018 | SP100 | | Oxford | Follow-up official |
SP100A | 6G5P | 29/03/2018 | SP100 | | Oxford | Follow-up official |
BRD4A | 6G0O | 19/03/2018 | BRD4 | | Oxford | Follow-up not counted |
BRD4A | 6G0P | 19/03/2018 | BRD4 | | Oxford | Follow-up not counted |
BRD4A | 6G0Q | 19/03/2018 | BRD4 | | Oxford | Follow-up not counted |
BRD4A | 6G0R | 19/03/2018 | BRD4 | | Oxford | Follow-up not counted |
BRD4A | 6G0S | 19/03/2018 | BRD4 | | Oxford | Follow-up not counted |
DPAGT1A | 6FWZ | 07/03/2018 | DPAGT1 | Neurobiology | Oxford | Follow-up official |
RIPK2 | 6FU5 | 28/02/2018 | RIPK2 | Cancer | Oxford | MedChem |
ULK3 | 6FDY | 31/12/2017 | ULK3 | Cancer | Oxford | Counted |
ULK3 | 6FDZ | 31/12/2017 | ULK3 | Cancer | Oxford | Follow-up official |
RIPK2A | 6ES0 | 19/10/2017 | RIPK2 | | Oxford | |
STK10 | 6EIM | 18/10/2017 | STK10 | Cancer | Oxford | MedChem |
JARID1BA | 6EIN | 29/09/2017 | KDM5B | Cancer | Oxford | |
JARID1BA | 6EIU | 29/09/2017 | KDM5B | Cancer | Oxford | |
JARID1BA | 6EIY | 29/09/2017 | KDM5B | Cancer | Oxford | |
JARID1BA | 6EJ0 | 29/09/2017 | KDM5B | Cancer | Oxford | |
JARID1BA | 6EJ1 | 29/09/2017 | KDM5B | Cancer | Oxford | |
JARID1BA | 6EK6 | 29/09/2017 | KDM5B | Cancer | Oxford | |
DENND1AA | 6EKK | 29/09/2017 | DENND1A | Neurobiology | Oxford | Official |
ACVR1Z | 6EIX | 19/09/2017 | ACVR1 | | Oxford | |
ACVR1A | 5OY6 | 08/09/2017 | ACVR1 | | Oxford | |
ACVR1A | 5OXG | 07/09/2017 | ACVR1 | | Oxford | |
ABCB8A | 5OCH | 30/06/2017 | ABCB8 | Metabolism | Oxford | Official |
DPAGT1A | 5O5E | 01/06/2017 | DPAGT1 | Neurobiology | Oxford | Follow-up official |
LIMK1A | 5NXC | 25/05/2017 | LIMK1 | Cancer | Oxford | Follow-up official |
LIMK2A | 5NXD | 25/05/2017 | LIMK2 | Cancer | Oxford | Follow-up official |
PARP14A | 5O2D | 20/05/2017 | PARP14 | Metabolism | Oxford | Official |
AASSA | 5O1P | 19/05/2017 | AASS | Metabolism | Oxford | Follow-up official |
AASSA | 5O1N | 19/05/2017 | AASS | Metabolism | Oxford | Follow-up official |
AASSA | 5O1O | 19/05/2017 | AASS | Metabolism | Oxford | Follow-up official |
BRD4 | 5NNC | 19/04/2017 | BRD4 | Cancer and epigenetics | Oxford | MedChem |
BRD4 | 5NND | 19/04/2017 | BRD4 | Cancer and epigenetics | Oxford | MedChem |
BRD4 | 5NNE | 19/04/2017 | BRD4 | Cancer and epigenetics | Oxford | MedChem |
BRD4 | 5NNF | 19/04/2017 | BRD4 | Cancer and epigenetics | Oxford | MedChem |
BRD4 | 5NNG | 19/04/2017 | BRD4 | Cancer and epigenetics | Oxford | MedChem |
DPYSL4A | 5NKS | 31/03/2017 | DPYSL4 | Neurobiology | Oxford | Official |
BRPF1B | 5MYG | 07/02/2017 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up not counted |
BRD2A | 5N2L | 07/02/2017 | BRD2 | Cancer, Chromatin and epigenetics | Oxford | Follow-up official |
TRIM33B | 5MR8 | 28/12/2016 | TRIM33 | Chromatin and epigenetics | Oxford | Official |
BRD7A | 5MQ1 | 19/12/2016 | BRD7 | Chromatin and epigenetics | Oxford | Follow-up official |
DCP2B | 5MP0 | 15/12/2016 | DCP2 | Metabolism | Oxford | Pending-Official Structure |
TAF1A | 5MG2 | 20/11/2016 | TAF1 | Cancer, Signalling | Oxford | Follow-up official |
CREBBP | 5TB6 | 09/11/2016 | CREBB | Cancer, Metabolism, Chromatin and epigenetics | Oxford | Follow-up official |
TDRD1A | 5M9N | 01/11/2016 | TDRD1 | | Oxford | Pending-Official Structure |
SND1A | 5M9O | 01/11/2016 | SND1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5T4V | 01/10/2016 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5T4U | 01/10/2016 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
DYRK2A | 5LXC | 20/09/2016 | DYRK2 | Cancer, Metabolism, Signalling, Neurobiology | Oxford | Follow-up official |
DYRK2A | 5LXD | 20/09/2016 | DYRK2 | Cancer, Metabolism, Signalling, Neurobiology | Oxford | Follow-up official |
NUDT4A | 5LTU | 16/09/2016 | NUDT4 | Metabolism | Oxford | Pending-Official Structure |
JARID1BA | 5LW9 | 15/09/2016 | JARID1B | Chromatin and epigenetics | Oxford | Follow-up official |
PCAFA | 5LVQ | 14/09/2016 | KAT2B | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
PCAFA | 5LVR | 14/09/2016 | KAT2B | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
BRD4A | 5LUU | 11/09/2016 | BRD4 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
SPIN2BA | 5LUG | 09/09/2016 | SPIN2B | Chromatin and epigenetics | Oxford | Pending-Official Structure |
NUDT7A | 5T3P | 26/08/2016 | NUDT7 | Metabolism | Oxford | Pending-Official Structure |
NUDT17A | 5LF8 | 30/06/2016 | NUDT17 | Metabolism | Oxford | Pending-Official Structure |
DPAGT1A | 5LEV | 30/06/2016 | DPAGT1 | Metabolism | Oxford | Official |
CREBBPA | 5J0D | 30/05/2016 | CREBBP | Cancer, Chromatin and epigenetics | Oxford | Pending-Official Structure |
PKD2A | 5K47 | 20/05/2016 | PKD2 | Metabolism | Oxford | Pending-Official Structure |
ZAKA | 5HES | 23/03/2016 | ZAK | Signalling | Oxford | Pending-Official Structure |
UTYC | 5FXV | 03/03/2016 | UTY | | Oxford | Follow-up official |
BRD9A | 5IGN | 28/02/2016 | BRD9 | Chromatin and epigenetics | Oxford | Follow-up official |
JARID1CA | 5FWJ | 17/02/2016 | JARID1C | Chromatin and epigenetics | Oxford | Follow-up official |
JARID1BA | 5FUN | 28/01/2016 | JARID1B | Chromatin and epigenetics | Oxford | Follow-up official |
JARID1BA | 5FUP | 28/01/2016 | JARID1B | Chromatin and epigenetics | Oxford | Follow-up official |
PB1A | 5HRV | 24/01/2016 | PB1 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
PB1A | 5HRW | 24/01/2016 | PB1 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
PB1A | 5HRX | 24/01/2016 | PB1 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
PB1A | 5FH6 | 21/12/2015 | PBRM1 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
PB1A | 5FH7 | 21/12/2015 | PBRM1 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
PB1A | 5FH8 | 21/12/2015 | PBRM1 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
JARID1BA | 5FPU | 21/12/2015 | KDM5B | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5FG4 | 20/12/2015 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5FG5 | 20/12/2015 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRD1A | 5FG6 | 20/12/2015 | BRD1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5FFV | 19/12/2015 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5FFW | 19/12/2015 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
BRPF1B | 5FFY | 19/12/2015 | BRPF1 | Chromatin and epigenetics | Oxford | Follow-up official |
DDR1A | 5FDP | 16/12/2015 | DDR1 | Signalling | Oxford | Follow-up official |
DDR1A | 5FDX | 16/12/2015 | DDR1 | Signalling | Oxford | Follow-up official |
PCAFA | 5FDZ | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE0 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE1 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE2 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE3 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE4 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE5 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE6 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE7 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE8 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
PCAFA | 5FE9 | 16/12/2015 | KAT2B | Cancer, Chromatin and epigenetics, Signalling, Neurobiology | Oxford | Follow-up official |
BRD4A | 5FBX | 14/12/2015 | BRD4 | Cancer, Chromatin and epigenetics, Signalling | Oxford | Follow-up official |
JMJD2DA | 5F5C | 04/12/2015 | KDM4D | Chromatin and epigenetics | Oxford | Follow-up official |
JMJD2AA | 5F5I | 04/12/2015 | KDM4A | Chromatin and epigenetics | Oxford | Follow-up official |
JMJD2DA | 5F5A | 04/12/2015 | KDM4D | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENB | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENC | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENE | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENF | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENH | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENI | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
PHIPA | 5ENJ | 09/11/2015 | PHIP | Chromatin and epigenetics | Oxford | Follow-up official |
BRD2A | 5EK9 | 03/11/2015 | BRD2 | Cancer, Chromatin and epigenetics | Oxford | Follow-up official |
BRD9A | 5E9V | 15/10/2015 | BRD9 | Chromatin and epigenetics | Oxford | Follow-up official |
ASPHA | 5APA | 16/09/2015 | ASPH | Metabolism | Oxford | Pending-Official Structure |
SMARCA2B | 5DKC | 03/09/2015 | SMARCA2 | Chromatin and epigenetics | Oxford | Follow-up official |
SMARCA4A | 5DKD | 03/09/2015 | SMARCA4 | Chromatin and epigenetics | Oxford | Follow-up official |
SMARCA2B | 5DKH | 03/09/2015 | SMARCA2 | Chromatin and epigenetics | Oxford | Follow-up official |
BAZ2BA | 5CUE | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CUG | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
JMJD2AA | 5A7N | 24/07/2015 | JMJD2A | Chromatin and epigenetics | Oxford | Follow-up official |
JMJD2AA | 5A7O | 24/07/2015 | JMJD2A | Chromatin and epigenetics | Oxford | Follow-up official |
JMJD2AA | 5A7P | 24/07/2015 | JMJD2A | Chromatin and epigenetics | Oxford | Follow-up official |
JMJD2AA | 5A7Q | 24/07/2015 | JMJD2A | Chromatin and epigenetics | Oxford | Follow-up official |
JMJD2AA | 5A7S | 24/07/2015 | JMJD2A | Chromatin and epigenetics | Oxford | Follow-up official |
BAZ2BA | 5CU8 | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CUA | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CUB | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CUC | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CUD | 24/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQ4 | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQ5 | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQ6 | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQ7 | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQ8 | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQA | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
POLQA | 5A9F | 21/07/2015 | POLQ | Cancer | Oxford | Follow-up official |
POLQA | 5A9J | 21/07/2015 | POLQ | Cancer | Oxford | Follow-up official |
BAZ2BA | 5CQ3 | 21/07/2015 | BAZ2B | Cancer | Oxford | Follow-up official |
RIPK2A | 4C8B | 30/09/2013 | RIPK2 | Cancer | Oxford | Pending-Official Structure |
DDR1A | 4BKJ | 26/04/2013 | DDR1A | | Oxford | Follow-up official |
DDR1A | 4CKR | 26/04/2013 | DDR1 | | Oxford | Follow-up not counted |
DDR1A | 3ZOS | 22/02/2013 | DDR1 | | Oxford | Pending-Official Structure |